DISCO Pharmaceuticals is a biotechnology company that operates a surfaceome mapping platform designed to identify novel cancer-selective targets for the development of antibody-based therapies
DISCO Pharmaceuticals is a biotechnology company that operates a surfaceome mapping platform designed to identify novel cancer-selective targets for the development of antibody-based therapies.